CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278 | -94.4% | 121 | -89.9% | 0.00% | – |
| Q1 2022 | $5,000 | -61.5% | 1,203 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -23.5% | 1,203 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | -97.7% | 1,203 | -98.1% | 0.00% | -100.0% |
| Q2 2021 | $728,000 | +118.6% | 62,563 | +128.1% | 0.00% | 0.0% |
| Q1 2021 | $333,000 | -47.6% | 27,430 | -46.1% | 0.00% | 0.0% |
| Q4 2020 | $636,000 | +27.7% | 50,897 | +53.5% | 0.00% | 0.0% |
| Q3 2020 | $498,000 | -38.4% | 33,150 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $809,000 | +15.4% | 33,150 | -33.2% | 0.00% | 0.0% |
| Q1 2020 | $701,000 | -15.3% | 49,653 | -4.9% | 0.00% | 0.0% |
| Q4 2019 | $828,000 | +1135.8% | 52,233 | +557.7% | 0.00% | – |
| Q3 2019 | $67,000 | – | 7,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |